These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38154422)

  • 1. Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review.
    Bechini A; Salvati C; Bonito B; Del Riccio M; Stancanelli E; Bruschi M; Ionita G; Iamarino JA; Bentivegna D; Buscemi P; Ciardi G; Cosma C; Stacchini L; Conticello C; Bega M; Paoli S; Schirripa A; Bertizzolo L; Muzii B; Azzi MV; Parisi S; Trippi F; Bonanni P; Boccalini S
    Public Health; 2024 Feb; 227():103-111. PubMed ID: 38154422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare resource utilisation and costs in infants with confirmed respiratory syncytial virus infections: a national population cohort study.
    Han HJ; Ryu D; Kim JY; Jang S; Suh HS
    BMC Infect Dis; 2024 Oct; 24(1):1152. PubMed ID: 39396944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review.
    Poshtiban A; Wick M; Bangert M; Damm O
    BMC Infect Dis; 2024 Aug; 24(1):844. PubMed ID: 39164625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inpatient burden of respiratory syncytial virus (RSV) in Switzerland, 2003 to 2021: an analysis of administrative data.
    Stucki M; Lenzin G; Agyeman PK; Posfay-Barbe KM; Ritz N; Trück J; Fallegger A; Oberle SG; Martyn O; Wieser S
    Euro Surveill; 2024 Sep; 29(39):. PubMed ID: 39328156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of disease and cost of illness of infants less than 6 months of age hospitalised with respiratory syncytial virus in Denmark - a 10-year national register-based study.
    von Linstow ML; Rudolfsen JH; Olsen J; Skovdal M; Staerke NB
    BMC Infect Dis; 2024 Oct; 24(1):1098. PubMed ID: 39363313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya.
    Nyiro JU; Nyawanda BO; Mutunga M; Murunga N; Nokes DJ; Bigogo G; Otieno NA; Lidechi S; Mazoya B; Jit M; Cohen C; Moyes J; Pecenka C; Baral R; Onyango C; Munywoki PK; Vodicka E
    BMC Public Health; 2024 Sep; 24(1):2410. PubMed ID: 39232690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Burden of Medically Attended Respiratory Syncytial Virus Infections Among Privately Insured Children Under 5 Years of Age in the USA.
    Tran PT; Nduaguba SO; Wang Y; Diaby V; Finelli L; Choi Y; Winterstein AG
    Influenza Other Respir Viruses; 2024 Jul; 18(7):e13347. PubMed ID: 38951044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of respiratory syncytial virus in adults in Germany - a health claims analysis between 2015 and 2018.
    Huebbe B; Mocek A; Manz KC; Vivirito A; Bayer LJ; Norris R; Schiffner-Rohe J; von Eiff C; Lade C
    J Med Econ; 2024; 27(1):1063-1075. PubMed ID: 39105626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.
    Fortunato F; Campanozzi A; Maffei G; Arena F; Carri VD; Rollo T; Lopalco PL; Martinelli D
    Ital J Pediatr; 2024 Mar; 50(1):45. PubMed ID: 38454523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RSV hospitalisation and healthcare utilisation in moderately prematurely born infants.
    Shefali-Patel D; Paris MA; Watson F; Peacock JL; Campbell M; Greenough A
    Eur J Pediatr; 2012 Jul; 171(7):1055-61. PubMed ID: 22302458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the economic burden of respiratory syncytial virus infections in infants in Vietnam: a cohort study.
    Do LAH; Vodicka E; Nguyen A; Le TNK; Nguyen TTH; Thai QT; Pham VQ; Pham TU; Nguyen TN; Mulholland K; Cao MT; Le NTN; Tran AT; Pecenka C
    BMC Infect Dis; 2023 Feb; 23(1):73. PubMed ID: 36747128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy.
    Dovizio M; Veronesi C; Bartolini F; Cavaliere A; Grego S; Pagliaro R; Procacci C; Ubertazzo L; Bertizzolo L; Muzii B; Parisi S; Perrone V; Baraldi E; Bozzola E; Mosca F; Esposti LD
    Ital J Pediatr; 2024 Mar; 50(1):57. PubMed ID: 38528616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.
    Andabaka T; Nickerson JW; Rojas-Reyes MX; Rueda JD; Bacic Vrca V; Barsic B
    Cochrane Database Syst Rev; 2013 Apr; (4):CD006602. PubMed ID: 23633336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study.
    Thampi N; Knight BD; Thavorn K; Webster RJ; Lanctot K; Hawken S; McNally JD
    CMAJ Open; 2021; 9(4):E948-E956. PubMed ID: 34667075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012.
    Reeves RM; Hardelid P; Gilbert R; Warburton F; Ellis J; Pebody RG
    Influenza Other Respir Viruses; 2017 Mar; 11(2):122-129. PubMed ID: 28058797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.
    Garegnani L; Styrmisdóttir L; Roson Rodriguez P; Escobar Liquitay CM; Esteban I; Franco JV
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013757. PubMed ID: 34783356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
    Simões EAF; Chirikov V; Botteman M; Kwon Y; Kuznik A
    J Infect Dis; 2020 Mar; 221(8):1256-1270. PubMed ID: 31165865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RE: 'Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review'.
    Murillo-Zamora E; Mendoza-Cano O
    Public Health; 2024 Mar; 228():e3. PubMed ID: 38408878
    [No Abstract]   [Full Text] [Related]  

  • 19. Respiratory syncytial virus--the unrecognised cause of health and economic burden among young children in Australia.
    Ranmuthugala G; Brown L; Lidbury BA
    Commun Dis Intell Q Rep; 2011 Jun; 35(2):177-84. PubMed ID: 22010512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
    Amand C; Tong S; Kieffer A; Kyaw MH
    BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.